EUVIMEDEUVIMED entdecken
Open Access

Disrupting the Oxidative Stress–Inflammation–Corneal Neovascularization Cycle with Ultrasmall Nanoparticles

Yue Wu iD, Nan Zhao, Xue Liu iD, Zhongxing Chen iD, Xiaomin Huang, Hongxian Pan iD, Mengmei Zhu, Zheyu Li, Xinyu Jiang, Xueyu Fu, Haochen Liu, Weiping Wang iD und 8 weitere

Advanced Materials · 2026

DOI: 10.1002/adma.73114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Yue Wu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, NHC Key Laboratory of Myopia and Related Eye Diseases, Eye & ENT Hospital, Fudan University, Shanghai,…. Hauptthemen laut MEDLINE: Oxidative Stress, Nanoparticles, Corneal Neovascularization, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, EYE & ENT Hospital of Fudan University High-level Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal neovascularization (CoNV) is a primary contributor to corneal scarring and vision impairment. During its initiation and progression, inflammatory reactions and oxidative stress synergistically trigger a pathological vicious cycle of oxidative stress, inflammation, and angiogenesis, posing a severe therapeutic challenge. In this study, a noninvasive transepithelial therapeutic strategy using ultrasmall polydopamine nanoparticles (UPDA NPs) with triple effects is developed. Their unique small size, approximately 3 nm, greatly enhances their radical‐scavenging capability and facilitates superior transepithelial delivery. Extensive research demonstrated that the obtained UPDA NPs possess excellent anti‐inflammatory, antioxidant, and anti‐angiogenic properties. By scavenging reactive oxygen species (ROS), activating the nuclear factor erythroid 2–related factor 2 (NRF2) antioxidant pathway, and suppressing multiple proangiogenic signaling cascades, they can disrupt the pathological cycle of inflammation, oxidative stress, and neovascularization at molecular, cellular, and animal levels. In an alkali‐burned mouse model, UPDA NPs notably reduce CoNV area and length, accelerate corneal repair, and exhibit no local or systemic toxicity, providing a new nanomedicine with translational potential for precise treatment of CoNV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressNanoparticlesCorneal NeovascularizationInflammationAnimalsPolymersMiceIndolesHumansReactive Oxygen SpeciesAntioxidantsNF-E2-Related Factor 2Angiogenesis InhibitorsAnti-Inflammatory AgentsParticle SizeCornea

Stichwörter der Autor:innen

corneal neovascularizationoxidative stresspolydopaminetransepithelial therapyultrasmall nanoparticles

Substanzen

PolymersIndolespolydopamineReactive Oxygen SpeciesAntioxidantsNF-E2-Related Factor 2Angiogenesis InhibitorsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, NHC Key Laboratory of Myopia and Related Eye Diseases, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China.
  • Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
  • School of Health Sciences and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
  • School of Ophthalmology and Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong; Department of Pharmacology & Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong; Laboratory of Molecular Engineering…

ORCID-Profile: Yue Wu, Xue Liu, Zhongxing Chen, Hongxian Pan, Weiping Wang, Manli Deng, Yi Shao, Wei Tao, Mei Yang, Xingtao Zhou, Jinhai Huang

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • EYE & ENT Hospital of Fudan University High-level Talents Program
  • Medical Engineering fund of Fudan University
  • Fund of Fudan University and Cao'ejiang Basic Research
  • National Health Commission National Key Clinical Discipline Construction Project
  • Joint Laboratory Fund of New Technologies in Ophthalmology and Optometry

Zitieren

APA

Wu, Y., Zhao, N., Liu, X., Chen, Z., Huang, X., Pan, H., Zhu, M., Li, Z., Jiang, X., Fu, X., Liu, H., Wang, W., Chen, X., Deng, M., Wu, J., Shao, Y., Tao, W., Yang, M., Zhou, X., & Huang, J. (2026). Disrupting the Oxidative Stress–Inflammation–Corneal Neovascularization Cycle with Ultrasmall Nanoparticles. Advanced Materials. https://doi.org/10.1002/adma.73114

Vancouver

Wu Y, Zhao N, Liu X, Chen Z, Huang X, Pan H, et al. Disrupting the Oxidative Stress–Inflammation–Corneal Neovascularization Cycle with Ultrasmall Nanoparticles. Advanced Materials. 2026. doi:10.1002/adma.73114

BibTeX
@article{Wu2026,
  author = {Wu, Yue and Zhao, Nan and Liu, Xue and Chen, Zhongxing and Huang, Xiaomin and Pan, Hongxian and Zhu, Mengmei and Li, Zheyu and Jiang, Xinyu and Fu, Xueyu and Liu, Haochen and Wang, Weiping and Chen, Xin and Deng, Manli and Wu, Jihong and Shao, Yi and Tao, Wei and Yang, Mei and Zhou, Xingtao and Huang, Jinhai},
  title = {Disrupting the Oxidative Stress–Inflammation–Corneal Neovascularization Cycle with Ultrasmall Nanoparticles},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.73114}
}
Kostenlos starten →